SCHEMBL24032216

SCHEMBL24032216

c1ccc(N(c2ccc(-c3nc4ccccc4s3)cc2)c2ccc3c(c2)oc2cc4c(cc23)oc2cc(N(c3ccccc3)c3ccc(-c5nc6ccccc6s5)cc3)ccc24)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ APP P05067 8/20 0.52
▸ RAB9A P51151 5/20 0.46
▸ KDM4E B2RXH2 4/20 0.46
▸ NPC1 O15118 4/20 0.46
▸ MAPT P10636 3/20 0.46
▸ GLA P06280 2/20 0.46
▸ GAA P10253 2/20 0.46
▸ ALDH1A1 P00352 2/20 0.46
▸ LMNA P02545 2/20 0.46
▸ MMP9 P14780 2/20 0.46
▸ MMP8 P22894 2/20 0.46
▸ PKM P14618 2/20 0.43
▸ SMN1; SMN2 Q16637 2/20 0.43
▸ PAX8 Q06710 2/20 0.43
▸ MEN1 O00255 2/20 0.43
▸ KMT2A Q03164 2/20 0.43
▸ NOD2 Q9HC29 1/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.43
▸ TNF P01375 1/20 0.43
▸ NOD1 Q9Y239 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26188390 0.93 APP (0.48) APPRAB9AKDM4ENPC1MAPT
SCHEMBL24155774 0.92 APP (0.53) APPRAB9AKDM4ENPC1MAPT
SCHEMBL24032215 0.91 APP (0.48) APPRAB9AKDM4ENPC1MAPT
SCHEMBL29299114 0.89 APP (0.48) APPRAB9AKDM4ENPC1MAPT
SCHEMBL24550627 0.87 KDM4E (0.40) APPRAB9AKDM4ENPC1MAPT
SCHEMBL24552538 0.87 KDM4E (0.40) APPRAB9AKDM4ENPC1MAPT
SCHEMBL26465294 0.87 APP (0.46) APPRAB9AKDM4ENPC1MAPT
SCHEMBL26465425 0.87 APP (0.46) APPRAB9AKDM4ENPC1MAPT
SCHEMBL23328677 0.87 APP (0.53) APPRAB9AKDM4ENPC1MAPT
SCHEMBL24032692 0.87 APP (0.44) APPRAB9AKDM4ENPC1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210355142-A1 COMPOUND, MATERIAL FOR AN ORGANIC ELECTROLUMINESCENT DEVICE AND APPLICATION THEREOF Shanghai Tianma AM-OLED Co., Ltd. (CN) 2021-11-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210355142-A1 COMPOUND, MATERIAL FOR AN ORGANIC ELECTROLUMINESCENT DEVICE AND APPLICATION THEREOF ALDH1A2, ACHE, EYA2 APP 2911/4885RAB9A 1945/4885KDM4E 556/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback